SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Shattuck Labs, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 1, 2022 – (NASDAQ: STTK)

PR Newswire


NEW YORK
, March 9, 2022 /PRNewswire/ — The Gross Law Firm issues the following notice on behalf of shareholders of Shattuck Labs, Inc..

Shareholders who purchased shares of STTK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/shattuck-labs-inc-loss-submission-form/?id=24413&from=4

CLASS PERIOD: This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded Shattuck securities: (1) pursuant and/or traceable to the registration statement and related prospectus issued in connection with Shattuck’s October 2020 initial public offering; and/or (2) between October 9, 2020 and November 9, 2021, inclusive.

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the collaboration agreement with Takeda was not solid; (2) Takeda and Shattuck would “mutually agree” to terminate the collaboration agreement in essentially one year; (3) as a result, Shattuck would cease to receive any future milestone, royalty, or other payments from Takeda; and (4) as a result, defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: April 1, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/shattuck-labs-inc-loss-submission-form/?id=24413&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of STTK during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 1, 2022. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Cision View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-shattuck-labs-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-april-1-2022–nasdaq-sttk-301498257.html

SOURCE The Gross Law Firm

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Electric Last Mile Solutions, Inc. f/k/a Forum Merger III Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 4, 2022 – (NASDAQ: ELMS)

PR Newswire


NEW YORK
, March 9, 2022 /PRNewswire/ — The Gross Law Firm issues the following notice on behalf of shareholders of Electric Last Mile Solutions, Inc. f/k/a Forum Merger III Corp..

Shareholders who purchased shares of ELMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/electric-last-mile-solutions-inc-f-k-a-forum-merger-iii-corp-loss-submission-form/?id=24414&from=4

CLASS PERIOD:
March 31, 2021 to February 1, 2022

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) ELMS’s previously issued financial statements were false and unreliable; (2) ELMS’s earlier reported financial statements would need restatement; (3) certain ELMS executives and/or directors purchased equity in the Company at substantial discounts to market value without obtaining an independent valuation; (4) on November 25, 2021 (Thanksgiving), the Company’s Board formed an independent Special Committee to conduct an inquiry into certain sales of equity securities made by and to individuals associated with the Company; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE: April 4, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/electric-last-mile-solutions-inc-f-k-a-forum-merger-iii-corp-loss-submission-form/?id=24414&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of ELMS during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 4, 2022. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Cision View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-electric-last-mile-solutions-inc-fka-forum-merger-iii-corp-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-april-4-2022–nasdaq-elms-301498223.html

SOURCE The Gross Law Firm

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Telos Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 8, 2022 – (NASDAQ: TLS)

PR Newswire


NEW YORK
, March 9, 2022 /PRNewswire/ — The Gross Law Firm issues the following notice on behalf of shareholders of Telos Corporation.

Shareholders who purchased shares of TLS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:
https://securitiesclasslaw.com/securities/telos-corporation-loss-submission-form/?id=24417&from=4

CLASS PERIOD:
November 19, 2020 to November 12, 2021

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Transportation Security Administration (“TSA”) and Centers for Medicare and Medicaid Services (“CMS”) contracts, which constituted a majority of the Company’s future revenues, were not on track to commence as represented at the end of 2021 and in 2022; (2) Defendants lacked a reasonable basis and sufficient visibility to provide and affirm the Company’s 2021 guidance in the face of the uncertainty surrounding the TSA and CMS contracts; (3) COVID-19- and hacking scandal-related headwinds were throwing off the timing for performance of the TSA and CMS contracts and their associated revenues; (4) as a result, the guidance provided by Defendants was not in fact “conservative”; (5) as a result of the delays, Telos would be forced to dramatically reduce its revenue estimates; and (6) as a result of the foregoing, Defendants’ statements about Telos’ business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.

DEADLINE: April 8, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/telos-corporation-loss-submission-form/?id=24417&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of TLS during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 8, 2022. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Cision View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-telos-corporation-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-april-8-2022–nasdaq-tls-301498245.html

SOURCE The Gross Law Firm

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of New Oriental Education & Technology Group Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 5, 2022 – (NYSE: EDU)

PR Newswire

NEW YORK, March 9, 2022 /PRNewswire/ — The Gross Law Firm issues the following notice on behalf of shareholders of New Oriental Education & Technology Group Inc..

Shareholders who purchased shares of EDU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/new-oriental-education-technology-group-inc-loss-submission-form/?id=24415&from=4

CLASS PERIOD:
April 24, 2018 to July 22, 2021

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) New Oriental’s revenue and operational growth was the result of deceptive marketing tactics and abusive business practices that flouted Chinese regulations and policies and exposed the Company to an extreme risk that more draconian measures would be imposed on the Company; (b) New Oriental had engaged in misleading and fraudulent advertising practices, including the provision of false and misleading discount Information designed to obfuscate the true cost of the Company’s programs to its customers; (c) New Oriental had falsified teacher qualifications and experience in order to attract customers and increase student enrollments; (d) New Oriental had defied prior government warnings against linking school enrollments with the provision of private tutoring services; (e) as a result of the foregoing, New Oriental was subject to an extreme undisclosed risk of adverse enforcement actions, regulatory fines and penalties, and the imposition of new rules and regulations adverse to the Company’s business and interests; and (f) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and lacked a reasonable, factual basis.

DEADLINE: April 5, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/new-oriental-education-technology-group-inc-loss-submission-form/?id=24415&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of EDU during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 5, 2022. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Cision View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-new-oriental-education–technology-group-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-april-5-2022–nyse-edu-301498261.html

SOURCE The Gross Law Firm

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 11, 2022 – (NASDAQ: FENC)

PR Newswire

NEW YORK, March 9, 2022 /PRNewswire/ — The Gross Law Firm issues the following notice on behalf of shareholders of Fennec Pharmaceuticals Inc..

Shareholders who purchased shares of FENC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/fennec-pharmaceuticals-inc-loss-submission-form-2/?id=24418&from=4

CLASS PERIOD:
May 28, 2021 to November 26, 2021

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Fennec had not successfully remediated, and overstated its efforts to remediate, issues with the manufacturing facility of its drug product manufacturer for PEDMARK, a new compound developed to reduce the incidence of hearing loss in children undergoing chemotherapy; (ii) as a result, the Food and Drug Administration likely to approve the Resubmitted Pedmark New Drug Application (“NDA”); (iii) accordingly, the regulatory and commercial prospects of the Resubmitted Pedmark NDA were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

DEADLINE: April 11, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/fennec-pharmaceuticals-inc-loss-submission-form-2/?id=24418&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of FENC during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 11, 2022. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Cision View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-fennec-pharmaceuticals-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-april-11-2022–nasdaq-fenc-301498242.html

SOURCE The Gross Law Firm

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Astra Space Inc. f/k/a Holicity Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 11, 2022 – (NASDAQ: ASTR)

PR Newswire

NEW YORK, March 9, 2022 /PRNewswire/ — The Gross Law Firm issues the following notice on behalf of shareholders of Astra Space Inc. f/k/a Holicity Inc..

Shareholders who purchased shares of ASTR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/astra-space-inc-f-k-a-holicity-inc-loss-submission-form/?id=24419&from=4

CLASS PERIOD:
February 2, 2021 to December 29, 2021

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Astra cannot launch “anywhere”; (2) Astra significantly overstated its addressable market; (3) Astra overstated the effectiveness of its designs and reliability; (4) Astra significantly overstated its plans for diversification and its broadband constellation plan; and (5) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

DEADLINE: April 11, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/astra-space-inc-f-k-a-holicity-inc-loss-submission-form/?id=24419&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of ASTR during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 11, 2022. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Cision View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-astra-space-inc-fka-holicity-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-april-11-2022–nasdaq-astr-301498237.html

SOURCE The Gross Law Firm

High Tide Subsidiary Blessed CBD Enters German Market

PR Newswire

The Company Continues to Expand Organically in Strategic International Markets

CALGARY, AB, March 9, 2022 /PRNewswire/ – High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, announced today that its U.K. based subsidiary Blessed CBD has entered the German market with online sales of its full spectrum CBD oils, gummies, capsules, creams and balms via its official website at www.BlessedCBD.de. Additional CBD product categories will be introduced for sale in the German market in the coming months. Fulfillment will be facilitated through High Tide’s existing Amsterdam based warehouse.

The largest CBD market in Europe, Germany is poised to experience a significant increase in demand for CBD products in the coming years. The growth in demand for high quality CBD products is an international phenomenon, with Fortune Business Insights projecting global demand to reach US$56 billion by 2028, equating to a Compound Annual Growth Rate of 47%.1

“Today’s news gives us a foothold in Germany which is poised to make up half of the E.U. cannabis market by 2024, according to Prohibition Partners. The move into Germany is part of our ongoing strategy to diversify our revenue base by identifying strategic opportunities and filling gaps in international cannabis markets through the organic expansion of our brands and products,”  said Raj Grover, President and Chief Executive Officer of High Tide. “Our unique and diversified ecosystem allows High Tide to drive revenue, EBITDA growth and market share gains internationally, today, without having to rely on the potential of federal cannabis legalization in the U.S. Our CBD business lines provide us with high margin sales opportunities which allow us to further expand market share in our core business of bricks and mortar cannabis sales by enhancing our consolidated margin profile,” added Mr. Grover.

“With all of the recent cannabis-related developments in Germany, I’m thrilled about Blessed CBD’s launch in Europe’s largest cannabis market. As promised, this is the first phase of our blueprint to take Blessed CBD to emerging new international markets, and to truly create a globally recognised CBD powerhouse,” said Vithurs (V) Thiru, Founder of Blessed CBD. “As part of our 2022 expansion plans, and by leveraging High Tide’s cross-platform synergies, Blessed CBD will also be accelerating growth in additional key markets such as the USA and other European countries. This is going to be an exciting year at High Tide,” added Mr. Thiru.

_______________________


1 Source: Fortune Business Insights https://www.fortunebusinessinsights.com/cannabidiol-cbd-market-103215

ABOUT HIGH TIDE

High Tide is a leading retail-focused cannabis company with bricks and mortar as well as global e-commerce assets. The Company is the largest Canadian retailer of recreational cannabis as measured by revenue, with 113 current locations spanning Ontario, Alberta, Manitoba and Saskatchewan. High Tide was featured in the third annual Report on Business Magazine’s ranking of Canada’s Top Growing Companies in 2021, and was named as one of the top 10 performing diversified industries stocks in the 2022 TSX Venture 50™. The Company is also North America’s first and only cannabis discount club retailer, featuring Canna Cabana, Meta Cannabis Co., and Meta Cannabis Supply Co. banners, with additional locations under development across the country. High Tide’s portfolio also includes retail kiosk and smart locker technology – Fastendr™. High Tide has been serving consumers for over a decade through its established e-commerce platforms including Grasscity.com, Smokecartel.com, Dailyhighclub.com, and Dankstop.com and more recently in the hemp-derived CBD space through Nuleafnaturals.com, FABCBD.com, and BlessedCBD.co.uk, as well as its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide’s strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

For more information about High Tide Inc., please visit www.hightideinc.com, its profile page on SEDAR at www.sedar.com, and its profile page on EDGAR at www.sec.gov.

ABOUT BLESSED CBD

Enigmaa Ltd., operating as Blessed CBD is one of the leading online retailers of hemp-derived CBD products in the U.K. The company provides a hemp-derived CBD marketplace with a wide variety of high-quality products and formulas, affordable pricing, rapid dependable shipping, and surprisingly personable customer service. Blessed CBD has been featured as the best UK CBD brand in several publications including The Mirror, Reader’s Digest, and Maxim Magazine.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this news release are forward-looking information or forward-looking statements. Such information and statements, referred to herein as “forward-looking statements” are made as of the date of this news release or as of the date of the effective date of information described in this news release, as applicable. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (generally, forward-looking statements can be identified by use of words such as “outlook”, “expects”, “intend”, “forecasts”, “anticipates”, “plans”, “projects”, “estimates”, “envisages, “assumes”, “needs”, “strategy”, “goals”, “objectives”, or variations thereof, or stating that certain actions, events or results “may”, “can”, “could”, “would”, “might”, or “will” be taken, occur or be achieved, or the negative of any of these terms or similar expressions, and other similar terminology) are not statements of historical fact and may be forward-looking statements.

Such forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to the ability of High Tide to execute on its business plan and that High Tide will receive one or multiple licenses from Alberta Gaming, Liquor & Cannabis, British Columbia’s Liquor Distribution Branch, Liquor, Gaming and Cannabis Authority of Manitoba, Alcohol and Gaming Commission of Ontario or the Saskatchewan Liquor and Gaming Authority permitting it to carry on its Canna Cabana Inc. business. High Tide considers these assumptions to be reasonable in the circumstances. However, there can be no assurance that any one or more of the government, industry, market, operational or financial targets as set out herein will be achieved. Inherent in the forward-looking statements are known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements, or industry results, to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements.

The forward–looking statements contained herein are current as of the date of this news release. Except as required by law, High Tide does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances. Any and all forward-looking statements included in this news release are expressly qualified by this cautionary statement, and except as otherwise indicated, are made as of the date of this news release.


This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933 (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons (as defined in the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration is available.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-subsidiary-blessed-cbd-enters-german-market-301498582.html

SOURCE High Tide Inc.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Acutus Medical, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 18, 2022 – (NASDAQ: AFIB)

PR Newswire


NEW YORK
, March 9, 2022 /PRNewswire/ — The Gross Law Firm issues the following notice on behalf of shareholders of Acutus Medical, Inc..

Shareholders who purchased shares of AFIB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/acutus-medical-inc-loss-submission-form/?id=24420&from=4

CLASS PERIOD: This lawsuit is on behalf of all purchasers of Acutus common stock between May 13, 2021 and November 11, 2021, inclusive.

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) a material percentage of the Company’s AcQMap imaging and mapping systems under evaluation had been randomly installed at sites with little, if any, consideration given to whether the healthcare providers at the selected locations were likely to adopt, or desire, the Company’s products; (b)  a material percentage of the AcQMap systems under evaluation had been installed in locations where the Company did not possess the infrastructure necessary to appropriately educate, train, and support medical service providers on the system’s operations; (c) as a result of (a) and (b) above, defendants were in the process of designing a strategic plan to terminate and relocate approximately 20% of then-existing AcQMap systems evaluation arrangements; (d) the Company’s management discussion and analysis  was materially false and misleading and failed to disclose that the termination and relocation of approximately 20% of existing AcQMap systems evaluation arrangements was reasonably likely to have a material adverse effect on the Company’s 2021 financial results; and (e) the Company’s risk factor discussions were materially false and misleading and made reference to potential risks without disclosing that such risks were then-existing or adequately describing the specific nature of the risks then facing the Company.

DEADLINE: April 18, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/acutus-medical-inc-loss-submission-form/?id=24420&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of AFIB during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 18, 2022. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Cision View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-acutus-medical-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-april-18-2022–nasdaq-afib-301498269.html

SOURCE The Gross Law Firm

WHAT MOVES HER® CAMPAIGN EXPANDS COMMITMENT TO COLDWELL BANKER COMMERCIAL WOMEN

PR Newswire

MADISON, N.J., March 9, 2022 /PRNewswire/ — Coldwell Banker Commercial, a Realogy (NYSE: RLGY) brand, today announces its offering of What Moves Her, a trailblazing campaign that supports the growth of women in real estate. Utilizing the What Moves Her program, Coldwell Banker Commercial will focus on elevating careers, empowering the community and supporting the success of women within the network. The expansion marks Coldwell Banker Commercial’s ongoing commitment to celebrating women and creating new business opportunities.     

What Moves Her was introduced in 2020 by Sue Yannaccone when she served as regional EVP at Coldwell Banker Realty, and later expanded across the Realogy network of brands when she assumed her current role as the President & CEO of Realogy Franchise Group. The program is designed to inspire and support all women to find their path to leadership. Additional goals of the organization include connecting brokers, showcasing Coldwell Banker Commercial’s core values and broadening the network of top talent through a new ambassador program.

“What Moves Her is exactly the kind of program Coldwell Banker Commercial needs to perpetuate continuous growth, provide support and elevate women in commercial real estate,” said Liz Gehringer, president of Coldwell Banker Affiliate Business and COO, Coldwell Banker Real Estate, LLC. “Some of the industry’s greatest female leaders proudly call Coldwell Banker Commercial home. Having represented billions in sales volume, leaders such as Leesa Harper-Rispoli, Coldwell Banker Commercial Alamo City, winner of the inaugural Women on the Move Award, Sheri Arnold, Coldwell Banker Commercial Arnold and Associates, and Molly Hamrick, Coldwell Banker Commercial Premier, just to name a few. Together, we will create new opportunities for our network and continue to celebrate the incredible achievements of women within our ranks and our industry.”

In 2022, Coldwell Banker Commercial sponsored What Moves Her™ activities will focus on connecting women in the commercial real estate industry to support their professional and business growth. These activities include quarterly virtual education events, networking opportunities, leveraging research and data and continued recognition for women in commercial real estate. In addition, Coldwell Banker Commercial will be hosting its third CBC Chatter event on March 31. The topic is FinTech and includes a panel of trailblazers in this space: Marissa Limsiaco, co-founder and president of Otso; Donna Salvatore, founder and CEO of Megalytics; and Poonam Sharma, founding partner at Arden Digital Ventures.

“Coldwell Banker Commercial would not be where we are today without the incredible women in our network,” said Dan Spiegel, senior vice president and managing director of Coldwell Banker Commercial. “I especially look forward to sitting alongside our impressive female panel, inspired by What Moves Her, at the next CBC Chatter event to discuss how our work is affecting emerging tech sectors. As industries collide, it’s more important than ever to educate ourselves and take active steps to improve gender representation.”

Coldwell Banker Commercial proudly boast some of the leading women commercial brokers and owners in the industry and is committed to supporting women, promoting their leadership development within the industry, representing their values, and providing resources to develop their leadership capabilities.  

Please visit WomenofCBC.com or cbcworldwide.com to learn more or follow the social media conversations on LinkedIn, Facebook and Twitter.


About Coldwell Banker Commercial

Coldwell Banker Commercial® franchised companies provide commercial real estate solutions serving the needs of owners and occupiers in the leasing, acquisition, and disposition of all property types. Since 1906, the Coldwell Banker Commercial brand has been a premier provider of real estate, recognized globally as a company that puts the client first while delivering individual, distinctly different service. With a collaborative network of independently owned and operated affiliates, the Coldwell Banker Commercial organization comprises almost 200 companies and more than 2,000 professionals throughout the U.S. and internationally. For additional information, visit https://www.cbcworldwide.com.


About Realogy Holdings Corp.



Realogy Holdings Corp.
 (NYSE: RLGY) is moving the real estate industry to what’s next. As the leading and most integrated provider of U.S. residential real estate services encompassing franchise, brokerage, relocation, and title and settlement businesses as well as a mortgage joint venture, Realogy supported approximately 1.5 million home transactions in 2021. The company’s diverse brand portfolio includes some of the most recognized names in real estate: Better Homes and Gardens® Real Estate, CENTURY 21®Coldwell Banker®Coldwell Banker Commercial®Corcoran®ERA®, and Sotheby’s International Realty®. Using innovative technology, data and marketing products, high-quality lead generation programs, and best-in-class learning and support services, Realogy fuels the productivity of its approximately 196,700 independent sales agents in the U.S. and approximately 136,700 independent sales agents in 118 other countries and territories, helping them build stronger businesses and best serve today’s consumers. Recognized for ten consecutive years as one of the World’s Most Ethical Companies, Realogy has also been designated a Great Place to Work four years in a row and is one of LinkedIn’s 2021 Top Companies in the U.S. and honored on the Forbes list of World’s Best Employers 2021.


Media Contact:
 
Rachel Kasab
CURICH|WEISS
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/what-moves-her-campaign-expands-commitment-to-coldwell-banker-commercial-women-301498729.html

SOURCE Coldwell Banker Commercial

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Oak Street Health, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 14, 2022 – (NYSE: OSH)

PR Newswire


NEW YORK
, March 9, 2022 /PRNewswire/ — The Gross Law Firm issues the following notice on behalf of shareholders of Oak Street Health, Inc..

Shareholders who purchased shares of OSH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/oak-street-health-inc-loss-submission-form/?id=24408&from=4

CLASS PERIOD:
August 6, 2020 to November 8, 2021

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Oak Street maintained relationships with third-party marketing agents likely to provoke law enforcement scrutiny; (2) Oak Street was providing free transportation to federal health care beneficiaries in a manner that would provoke law enforcement scrutiny; (3) these activities may be violations of the False Claims Act; (4) as such, Oak Street was at heightened risk of investigation by the U.S. Department of Justice and/or other federal law enforcement agencies; (5) as a result, Oak Street was subject to adverse impacts related to defense and settlement costs and diversion of management resources; and (6) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE: March 14, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/oak-street-health-inc-loss-submission-form/?id=24408&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of OSH during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 14, 2022. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

Cision View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-oak-street-health-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-march-14-2022–nyse-osh-301498296.html

SOURCE The Gross Law Firm